Encision Enters Into Sales Representation Agreement With Caldera Medical
Posted on: Wednesday, 25 March 2009, 05:52 CDT
"We are pleased to expand our product offerings to a key group of our target customers. Caldera's products are consistent with our desire to offer 'best in class' products to the surgical market," said
"Through Encision's experienced sales representatives, we will expand coverage throughout the U.S. market and strengthen our presence in the marketplace. This is especially important as we continue to broaden our product portfolio with innovative new technologies," said
About Encision:
Encision designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in
About Caldera:
Caldera is dedicated to bringing innovative medical devices to the marketplace. Caldera focuses exclusively on differentiated, high-impact products across the gynecology, urology and urogynecology specialties. Caldera is a privately held company located in
In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase net sales through the Company's distribution channels, insufficient quantity of new account conversions, insufficient cash to fund operations, scale up production to meet delivery obligations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission.
CONTACT: Marcia McHaffie, Encision Inc., 303-444-2600, mmchaffie@encision.comSOURCE Encision Inc.
Source: PR Newswire
Related Articles
- Experts Outline Challenges to Translational Research in the United States at a Capitol Hill Briefing, Emphasizing the Importance of Bringing Medical Innovation from 'Bench to Bedside'
- Inverness Medical Innovations Announces Fourth Quarter 2008 Results
- BioCurex Licenses RECAF Technology to Inverness Medical Innovations
- Cleveland Clinic Unveils 'Top 10' Medical Innovations For 2008
- Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
- StatSure Diagnostic Systems Signs Deal With Inverness Medical Innovations for Rapid HIV Test
- Biophan Presents at MRI Safety Symposium; MRI Safety Key Topic at the Society for Medical Innovation and Technology (SMIT) 2006 Conference
- LifeNet Announces Expanded Alliance With St. Jude Medical to Include Vascular Allograft Products
- Inverness Medical Innovations Announces Clarification on Its Statement Regarding Avian Flu Claim
- Inverness Medical Innovations Announces FDA Clearance for Avian Influenza Claim With the BinaxNOW(R) Influenza A & B Test
User Comments (0)

RSS Feeds